Cancer is the #1 cause of death in Singapore. According to the Ministry of Health (MOH), cancer drug spending grew by 20% per year between 2016 – 2019, which is not sustainable. To address this, MOH had announced changes to the Medishield Life and Integrated Shield Plan (IP) coverage, and established a Cancer Drug List (CDL). What is the Cancer Drug List? The CDL is a list of claimable outpatient cancer treatments. This was created to ensure that the cost of cancer treatment and insurance premiums remain affordable over time. See the full list on MOH’s website

When does this take effect?

Before April 2023, cancer treatment coverage is processed “as charged” under hospitalisation insurance plans (Integrated Shield Plans). However, from April 2023, cancer treatment coverage on the Cancer Drug List will be limited, and non-CDL drugs will only be covered by riders with varying limits between insurers. By now, you should have already been approached by your insurance agents with regards to this update....